NewcelX Ltd.

US$2.72As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NCELHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.57
PE TTM —
TSR TTM (62.63%)
Mkt cap US$15.73M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.45
26.56%
(87.52%)
Hold 0|9|8|2|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
(3.16%)
(3.14%)
4.08%
3.93%
Revenue$M
0.795
0.817
0.864
0.842
19.29%
15.58%
17.96%
11.74%
Peers (US$15.74M)
Cap (US$)
PE
59.55M
—
15.80M
—
Capital
TTM
5Y
10Y
Leveragex
0.985
(0.048)
(0.035)
EBIT/Intx
3.363
0.257
0.157
Own earn%
(18.27)
48.45
51.59
Sh yield%
15.06
10.01
9.55
Owners
Insiders/Inst%
7.63
40.91
Short interest%
5.11
SBC / revenue%
0.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
7–12
$1 testx
—
Incr. ROIC%
35